688221 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Frontier Biotechnologies, Inc. engages in the research, development, production, and sale of medicines. It offers hypercholesterolemia treatment, broadly neutralising antibody, and transdermal patch for musculoskeletal pain. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688221 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company